Chairperson(s) : Chi Dae Kim (Pusan National University, Republic of Korea), Young-Guen Kwon (Young-Guen Kwon, Republic of Korea)
Panel(s) : Yongseek Park (Kyung Hee University, Republic of Korea), Jun Hwan Cho (Chung-Ang University, Republic of Korea), Jae-Hoon Choi (Hanyang University, Republic of Korea)
-
Biobank resources for human metabolic and vascular research
Hyun Joung Lim National Institute of Health, Republic of Korea 13:00~13:20 -
Leveraging biobank platforms to study cardiometabolic physiology and disease
Heiko Bugger Medical University of Graz, Austria 13:20~13:40 -
Integrative analysis of metabolic dysfunction
Young Yang Sookmyung Women\'s University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
Chairperson(s) : Hayato Tada (Kanazawa University, Japan), Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Sung Hee Choi (Seoul National University, Republic of Korea)
-
Refined risk assessment in FH
Sayaka Funabashi Kyorin University, Japan 14:30~14:48 - Q&A 14:48~14:52
-
Cause of death in FH
Chan Joo Lee Yonsei University, Republic of Korea 14:52~15:10 - Q&A 15:10~15:14
-
Experience on new drugs for FH: including lomitapide & evinacumab
Hayato Tada Kanazawa University, Japan 15:14~15:32 - Q&A 15:32~15:36
-
Genome editing for precision medicine
HyongBum Kim Yonsei University, Republic of Korea 15:36~15:54 - Q&A 15:54~15:58
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea), Jae Hyoung Park (Korea University, Republic of Korea)
Panel(s) : Osung Kwon (The Catholic University of Korea, Republic of Korea), Gyu Chul Oh (The Catholic University of Korea, Republic of Korea), Dae Young Cheon (Hallym University, Republic of Korea)
-
Do East Asians need lower statin intensity? ethnic differences in LDL-C response and safety
Eun Jeong Cho Chung-Ang University, Republic of Korea 16:10~16:28 -
Why TG is important in Asians?
Daisaku Masuda Rinku General Medical Center, Japan 16:28~16:46 -
Genetic stratification and treatment response in Korean severe hypertriglyceridemia: a prospective multicenter registry study
Hun Jee Choe Hallym University, Republic of Korea 16:46~17:04 -
Chylomicronemia: past, present and future
Hiroaki Okazaki Teikyo University, Japan 17:04~17:22 - Panel Discussion 17:22~17:40
Chairperson(s) : Jae Hyoung Park (Korea University, Republic of Korea)
Chairperson(s) : Sungha Park (Yonsei University, Republic of Korea), Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Gyu Chul Oh (The Catholic University of Korea, Republic of Korea), Ji-Yong Jang (National Health Insurance Service Ilsan Hospital, Republic of Korea), Yun Kyung Cho (University of Ulsan, Republic of Korea)
-
Bempedoic acid: LDL-C lowering beyond statins - evidence and clinical role
Chewan Lim Catholic Kwandong University, Republic of Korea 08:30~08:50 -
Optimizing non-statin therapy: PCSK9 inhibitors and inclisiran
Kyung-Hee Kim Incheon Sejong Hospital, Republic of Korea 08:50~09:10 -
Emerging Lp(a)-lowering therapies: siRNA, ASO, and beyond
Yu-Chen Wang Asia University, Taiwan 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : Kyong Soo Park (Konkuk University, Republic of Korea), Myung A Kim (Seoul National University, Republic of Korea)
Chairperson(s) : Donghoon Choi (Yonsei University, Republic of Korea), Kyung Woo Park (Seoul National University, Republic of Korea)
Panel(s) : Jaehyun Bae (Hallym University, Republic of Korea), Heung Yong Jin (Jeonbuk National University, Republic of Korea), Jung-Kyu Han (Seoul National University, Republic of Korea)
-
Lipoprotein(a) in Korean patients: real-world data, cardiovascular risk, and clinical implications
Sang Min Park Eulji University, Republic of Korea 13:45~14:05 -
Lipoprotein(a) and coronary atherosclerosis in Vietnam: real-world data and emerging cardiovascular risk
Anh Tien Hoang Hue University, Vietnam 14:05~14:25 -
Measuring Lipoprotein(a) in clinical practice: assay challenges, standardization, and interpretation
Sang-Guk Lee Yonsei University, Republic of Korea 14:25~14:45 - Panel Discussion 14:45~15:15
Chairperson(s) : Sang Yup Lim (Korea University, Republic of Korea)
Panel(s) : Byung Sik Kim (Hanyang University, Republic of Korea), Eun Jung Rhee (Sungkyunkwan University, Republic of Korea), Jang Hoon Lee (Kyungpook National University, Republic of Korea)
-
CETP inhibition revisited: obicetrapib for LDL-C reduction and ASCVD risk management
Mariko Harada-Shiba Osaka Medical and Pharmaceutical University, Japan 16:10~16:30 -
APOC3 inhibition: targeting triglyceride-rich lipoproteins and residual risk
Jin Wi Gachon University, Republic of Korea 16:30~16:50 -
ANGPTL3 inhibition: expanding therapeutic opportunities beyond LDL-C
Hye Moon Chung Kyung Hee University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Kwang-Won Kim (Gachon University, Republic of Korea), Kwang Kon Koh (Gachon University, Republic of Korea)
Chairperson(s) : Chin-Chou Huang (Taipei Veterans General Hospital, Taiwan)
Panel(s) : Young Sang Lyu (Chosun University, Republic of Korea), Hong Seok Lim (Ajou University, Republic of Korea), Hansaem Jung (Jeong Hansaem Internal Medicine Clinic, Republic of Korea)
-
The emerging role of ApoB and triglyceride-rich lipoproteins
Sin Yung Woo Konyang University, Republic of Korea 08:50~09:10 -
Beyond LDL-C: targeting inflammation and lipoprotein(a) to address residual cardiovascular risk in Asia
Ping-Yen Liu National Cheng Kung University, Taiwan 09:10~09:30 -
Cardiometabolic residual risk in Asia: diabetes, metabolic dysfunction, and vascular aging
Minkwan Kim Yonsei University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
Chairperson(s) : Hong Seog Seo (Korea University, Republic of Korea)
Chairperson(s) : Joon Hyung Doh (Inje University, Republic of Korea), Sang Yeub Lee (Chung-Ang University, Republic of Korea)
Panel(s) : Yong Hyun Park (Pusan National University, Republic of Korea), Hyun-Woong Park (Chungnam National University, Republic of Korea), Jong Shin Woo (Kyung Hee University, Republic of Korea), Soo Young Lee (Chung-Ang University, Republic of Korea)
-
Impact of lipid-lowering therapy on plaque stabilization and regression
Jong Young Lee Hallym University, Republic of Korea 13:00~13:15 -
Coronary microvascular dysfunction after PCI
Hyun Sung Joh Seoul National University, Republic of Korea 13:15~13:30 -
Discordance between CAC and coronary stenosis
Sang Hoon Shin Ewha Womans University, Republic of Korea 13:30~13:45 - Panel Discussion 13:45~14:00
Chairperson(s) : Yongseek Park (Kyung Hee University, Republic of Korea), Hyun Jae Kang (Seoul National University, Republic of Korea)
Panel(s) : Kyu-Yong Ko (Inje University, Republic of Korea), Hee-Dong Kim (Soonchunhyang University, Republic of Korea), Kwan Yong Lee (The Catholic University of Korea, Republic of Korea)
-
AI-CVD: opportunistic testing of coronary calcium and beyond
Nathan D. Wong University of California, Irvine, USA 14:10~14:28 -
A+4DCT: angio enhanced dynamic CT for non-invasive functional diagnosis of coronary artery disease
Joon Sang Lee Yonsei University, Republic of Korea 14:28~14:46 -
Application of AI to coronary angiography
Si-Hyuck Kang Seoul National University, Republic of Korea 14:46~15:04 -
AI-based retinomics: cardiovascular risk prediction using retinal imaging
Sahil Thakur Medical Affairs, Mediwhale Inc., Singapore 15:04~15:22 - Panel Discussion 15:22~15:40
Chairperson(s) : Borge G. Nordestgaard (University of Copenhagen, Denmark), Cheol-Young Park (Sungkyunkwan University, Republic of Korea)
Panel(s) : Seon Mee Kang (Soonchunhyang University, Republic of Korea), Min Kyung Lee (Hanyang University, Republic of Korea), Ji Eun Lee (Korea University, Republic of Korea)
-
ESC/EAS dyslipidemia guidelines: recent updates and evidence base
Meral Kayikcioglu Ege University, Türkiye 15:40~16:00 -
Korean perspectives on dyslipidemia guidelines: recent update and challenges
Jaehoon Chung Gachon University, Republic of Korea 16:00~16:20 -
Translating guidelines into practice
Wonjin Kim CHA University, Republic of Korea 16:20~16:40 - Panel Discussion 16:40~17:10
